Communication Bridge 3 Clinical Trial is now enrolling participants.
What is Primary Progressive Aphasia?
Primary progressive aphasia (PPA) is a clinical dementia syndrome that is caused by neurodegenerative diseases including Alzheimer’s disease or a form of Frontemporal Lobar Degeneration. Below, we break down the PPA term to uncover how each word contributes to the definition of the syndrome.
Primary
Impairment is prominent in a single domain (language) with relative sparing of other domains early on (e.g., memory, personality and perception)
Progressive
The impairment will get worse over time, since it is caused by neurodegenerative disease
Aphasia
Refers to the language impairment that individuals experience
Communication Bridge Trial Details
Communication Bridge is looking for adults with a diagnosis of Primary Progressive Aphasia (PPA) and their communication partners to participate in the Communication Bridge 3 intervention trial.
The trial is designed to identify evidence-based strategies to maximize communication participation and quality of life and minimize burden for persons with PPA and their communication partners.
Trial Details:
- Trial Location: All study components take place remotely via video chat (Zoom)
- Trial Length: ~18 months
- Trial Activities:
- Participants will recieve intervention sessions with licensed clinicians
- Exercises through a custom web-application
- Trial Costs: There are no costs to participate. Compensation will be provided.
How Do I Get Involved?
If you or somebody you know might be interested, please contact us at:
Phone: 1-855-824-7887
Email: cbtrial@uchicago.edu
Fax: 773-834-0083
If you are interested in other research opportunities and news from the HAARC Center, consider joining our research registry.